A new clinical trial has found that a fasting-mimicking diet, a carefully designed 5-day low-calorie eating plan, may help reduce symptoms and intestinal inflammation in people with Crohn's disease. The approach offers a potential complementary strategy for a condition that has long lacked clear dietary guidelines, though experts emphasize that patients should only attempt it under medical supervision .

What Exactly Is a Fasting-Mimicking Diet?

Unlike a full water fast, a fasting-mimicking diet (FMD) provides a carefully calibrated low-calorie, low-protein, plant-based meal plan over five consecutive days. The diet was originally developed by Valter Longo, a professor of gerontology and biological sciences at the University of Southern California. The key difference from intermittent fasting is that the FMD is a specific 5-day protocol done periodically, not daily time-restricted eating windows like the popular 16:8 approach .

The FMD is designed to trigger the body's fasting pathways, including autophagy and immune cell regeneration, while reducing the risks and difficulty associated with complete food restriction. In Crohn's disease, the immune system mistakenly attacks the lining of the gastrointestinal tract, causing chronic inflammation, pain, diarrhea, and fatigue. Current treatments focus primarily on suppressing the immune response with medications such as biologics and immunomodulators, but dietary interventions have remained frustratingly elusive .

What Did the Clinical Trial Find About Symptom Relief?

According to the trial findings reported in 2026, patients with mild to moderate Crohn's disease who completed cycles of the five-day fasting-mimicking diet showed improvements in clinical symptom scores and reductions in inflammatory biomarkers such as C-reactive protein . Participants reported feeling better relatively quickly, with some noting symptom relief after just the first cycle. The diet appeared to be well-tolerated, though researchers emphasized that patients followed the protocol under medical supervision.

The mechanism behind these benefits likely involves the diet's ability to reduce pro-inflammatory immune cells and promote regeneration of the intestinal lining. Previous preclinical work by Longo's group, published in Cell Reports, had shown that fasting-mimicking cycles could reduce intestinal inflammation and promote stem cell-driven tissue repair in mouse models of inflammatory bowel disease . The new human trial represents a critical step in translating those laboratory findings into clinical practice.

How to Approach a Fasting-Mimicking Diet Safely

• Medical Supervision Required: Never attempt a fasting-mimicking diet without consulting your gastroenterologist first. The protocol used in the trial was a specific, medically supervised plan, not simply eating less for five days.
• Nutritional Monitoring: Crohn's disease patients are often at risk of malnutrition, nutrient deficiencies, and unintended weight loss, which means any form of caloric restriction must be carefully monitored by a healthcare provider.
• Individualized Assessment: Dietary management of inflammatory bowel disease remains highly individualized, and what works for one patient may not work for another. Your gastroenterologist can help assess whether a supervised fasting-mimicking protocol might be appropriate alongside your current treatment plan.

Attempting an unsupervised version could worsen nutritional status or trigger a disease flare. The Crohn's and Colitis Foundation notes that the new research adds an important piece to the puzzle, but it does not replace standard medical treatment .

Can This Diet Replace Your Current Crohn's Medications?

No. The research suggests the diet may complement standard treatments, but it is not a replacement for medications such as biologics, immunomodulators, or corticosteroids. Patients should never stop prescribed medications without consulting their doctor. In research settings, the fasting-mimicking diet is typically repeated in monthly cycles, with five days of the restricted diet followed by a return to normal eating for the rest of the month .

While the trial results are encouraging, gastroenterologists urge caution. The new research represents a meaningful step forward for roughly 500,000 Americans living with Crohn's disease, but larger, longer-term trials are needed before the approach can be broadly recommended . If you have Crohn's disease and are interested in exploring dietary approaches, discuss options with your gastroenterologist, who can help determine whether a supervised fasting-mimicking protocol might be appropriate for your specific situation.